GAGA Share Market News

[hfe_template id='11223'] [ad_1] Brokerage firms offer varied perspectives on select stocks. Morgan Stanley is optimistic about Aditya Birla Capital, citing improvements across business segments and re-rating potential. Synopsis Brokerage firms provide insights on select stocks. Morgan Stanley is optimistic about Aditya Birla Capital, citing improvements across business segments. Nuvama maintains a Buy rating on Jubilant Ingrevia, highlighting solid margins. However, Nuvama is cautious on Tata Motors, reducing its target price due to muted growth projections. These recommendations offer a mixed outlook for investors. Brokerage firms have shared their latest views on select stocks, offering a mix of bullish and cautious takes for the next 12 months.Morgan Stanley remains upbeat on Aditya Birla Capital, citing broad-based improvements across business segments and potential for re-rating.Meanwhile, Nuvama Institutional Equities has reaffirmed a Buy on Jubilant Ingrevia, hig...

[hfe_template id='11223'] [ad_1] Shares of BSE rose 4.4% to their day’s high of Rs 7,265 on the NSE on Tuesday after the company’s board announced a total final dividend of Rs 23 per share for its shareholders while announcing the Q4 results, fixing May 14 as the record date for determining the shareholder eligibility for the same. The total dividend of Rs 23 consists of a special dividend of Rs 5 per share to commemorate 150 years of BSE, along with a regular dividend of Rs 18 per share. “This is to inform that the Board of Directors of BSE Limited (“the Company”) at its meeting held on Tuesday, May 6, 2025 (i.e., today), inter-alia, considered and approved the following: Recommended payment of a special dividend of Rs 5/- to commemorate the 150th year of BSE Limited and a payment of Rs 18/- as a regular dividend resulting into a final dividend of Rs 23/- per equity share of face value of Rs 2 each,” the company said in an exchange filing. Since the record date has been...

[hfe_template id='11223'] [ad_1] Indian benchmark indices ended with weekly declines of 1.4% amid growing tension between India and Pakistan. But a Saturday peace breakthrough between the two countries could calm the markets when they resume trade on Monday. A host of other important domestic and global events lined-up during the week, are also likely to impact the D-Street. On Friday, Nifty declined 265.80 points or 1.1% to end the day at 24,008. Selling pressure was across sectors but more prominent in private banks, realty and energy stocks. "Following a period of consolidation, Indian equity benchmarks experienced a sharp correction amid escalating geopolitical tensions between India and Pakistan, which fueled market volatility and triggered a shift toward risk-off sentiment. Geopolitical developments, particularly the ongoing tensions with Pakistan, will continue to remain in focus," Ajit Mishra, Senior Vice President, Research, Religare Broking said. Mark...

[hfe_template id='11223'] [ad_1] Despite heightened tensions at the borders, the announcement of an India-Pakistan ceasefire is expected to set Indian markets on an upward trajectory this week. The markets, which had been recovering from a recent correction, took a hit as tensions between the two countries escalated. Headline indices Sensex and Nifty fell over 1% on Friday. T However, it should be noted that the Indian government has said Pakistan violated the ceasefire agreement along the Line of Control (LOC) and the situation remains evolving by the minute. During the conflict, the stocks showed resilience with no major correction, which indicates strong underlying confidence. The ceasefire news is likely to further bolster that and support a market rebound. "With the announcement of a ceasefire, the lingering fear among investors is expected to ease further. As a result, we anticipate a positive start to the week," said Shruti Jain, Chief Strategy Officer, ...

[hfe_template id='11223'] [ad_1] Biocon shares are expected to be in the spotlight on Friday, May 9, after the company reported a significant 153% year-on-year (YoY) surge in its net profit to Rs 344 crore for the fourth quarter of the financial year 2025. Additionally, the company also posted consolidated revenue of Rs 4,454 crore, marking a 15% YoY increase on a like-for-like basis. The operating revenue rose by 15% to Rs 4,417 crore, after adjusting for BFI revenue. EBITDA surged by 16% to Rs 1,115 crore, with an EBITDA margin of 25%. Core EBITDA increased by 16% to Rs 1,363 crore, reflecting a core EBITDA margin of 31%. Additionally, Biocon invested Rs 231 crore in net R&D, representing 7% of revenue, excluding Syngene. Segment-wise, the Generics division, encompassing APIs and generic formulations, delivered revenue of Rs 1,048 crore, up 46% year-on-year. The Research Services segment, represented by Syngene, recorded Rs 1,018 crore in revenue, an 11% rise. Live...

[hfe_template id='11223'] [ad_1] Shares of Tata Motors are likely to be in focus on Wednesday after the company announced that shareholders have approved its plan to split into two listed entities, separating its passenger vehicle (PV) and commercial vehicle (CV) businesses. The restructuring move, first announced in March 2024, aims to unlock value by allowing each business to pursue independent growth strategies. The PV unit includes the luxury Jaguar Land Rover (JLR) brand, while the CV arm focuses on trucks, buses, and other commercial offerings. According to an exchange filing on Tuesday, the demerger plan was approved by 99.9995% of shareholders, with each receiving equal stakes in the two new listed companies. Also Read: Defence stocks in focus as India strikes terror camps in Pakistan, PoK under ‘Operation Sindoor’ Earlier last week, Tata Motors reported a 6.1% year-on-year decline in total vehicle sales to 72,753 units in April 2025, down from 77,521 units in t...

[hfe_template id='11223'] [ad_1] Global funds are returning to Indian stocks, signaling that this month’s rally in Asia’s best-performing equity market likely has more legs. Having largely been sellers in the months since Indian benchmarks scaled records in September, foreigners are coming back amid growing optimism that a domestically-driven economy will make the South Asian nation withstand the global trade war better than most peers. A sharp advance from this month’s low already boosted India’s market’s value by $489 billion to nearly $4.4 trillion at the end of last week. Overseas funds bought $589 million of Indian shares on a net basis last Friday, marking an eighth straight day of purchases, according to data compiled by Bloomberg. The buying streak means they have now invested about $680 million in April. At one point, they were sellers of more than $3 billion for the month. “Foreigners are coming back as India is perceived to be relatively better placed than oth...

[hfe_template id='11223'] [ad_1] Indian benchmark indices ended over 1% higher on Monday, with the BSE Sensex soaring over 1,000 points and the Nifty50 closing above 24,300. The rally was driven by heavyweight Reliance Industries after it reported better-than-expected earnings, while continued foreign inflows further boosted market sentiment. The 30-share BSE Sensex jumped 1,005.8 points, or 1.27%, to settle at 80,218, while the broader NSE Nifty gained 289 points, or 1.2%, closing at 24,328. The total market capitalization of BSE-listed companies rose by Rs 4.45 lakh crore, reaching Rs 426.03 lakh crore. All sectoral indices, except Nifty IT, ended in the green. The Nifty Auto, PSU Bank, Metal, Pharma, Realty, Healthcare, and Oil & Gas indices saw gains ranging from 1% to 3%. Here are top reasons behind today's market rally: Live Events 1) Better than expected RIL Q4 results Reliance Industries rose 5.3% after reporting a fourth-quarter profit that exceeded esti...

[hfe_template id='11223'] [ad_1] Shares of Niva Bupa Health Insurance Company, which recently debuted on the bourses, surged as high as 11.5% to an intraday high of Rs 86.40 on the BSE after domestic brokerage firm Motilal Oswal initiated coverage on the stock, foreseeing an upside potential of 29%. Motilal Oswal has initiated the coverage with a ‘buy’ rating and a target price of Rs 100. “We believe Niva has a strong position to harness the growth opportunity in the health insurance industry, backed by product innovation and customer base expansion. Investments in technology will give results in terms of operational efficiency and better profitability,” Motilal Oswal said in its report. The brokerage firm noted that Niva Bupa has emerged as one of the fastest-growing health insurers, delivering a CAGR of 34% during FY22- 25 and garnering the highest incremental market share in the retail health segment. The analysts at Motilal Oswal expect this growth momentum to stay s...

[hfe_template id='11223'] [ad_1] India's benchmark indices extended their winning streak to five sessions on Monday, supported by a weaker U.S. dollar and strong earnings from heavyweight lenders ICICI Bank and HDFC Bank, both of which hit record highs, boosting investor sentiment across the banking sector. The benchmark BSE Sensex gained 855.30 points or 1.09% to close at 79,408.50, while the broader Nifty 50 index closed at 24,125.55, higher by 273.90 points or 1.15%. Key factors behind today's rally: 1) Banking stocks lead the charge Banking stocks were at the forefront of Monday’s rally, with the Nifty Bank index surging past the 55,000 mark for the first time ever, ending 1.9% higher, powered by robust quarterly earnings from private sector majors. HDFC Bank jumped nearly 2% to a fresh 52-week high of Rs 1,950.70, while ICICI Bank climbed about 1% to a new all-time high of Rs 1,436.00. The strong results reinforced investor confidence, prompting brokerages t...

[hfe_template id='11223'] [ad_1] Markets staged a strong rebound, rallying over 4.5% during the holiday-shortened week, supported by positive signals from domestic and global developments. Benchmark indices opened the week with a sharp gap-up and extended their gains through the following sessions. Consequently, the Nifty and the Sensex ended near their weekly highs, closing at 23,851.65 and 78,553.20, respectively. The rally was largely driven by optimism over the deferral of tariffs and exemptions on select products, fueling hopes of trade negotiations. Markets also reacted positively to updates on a normal monsoon, easing retail inflation, which boosted rate cut expectations, and a stable global backdrop. “Index on weekly chart has formed a sizable bull candle with a higher high and higher low signaling continuation of the up move. The index in the process formed a higher high in the monthly chart, highlighting strength. Index to maintain overall positive bias and gra...

[hfe_template id='11223'] [ad_1] Foreign Institutional Investors (FIIs) extended their selling spree on Friday for the 9th successive session taking the monthly outflows to Rs 31,575 crore. They have been sellers in each of the previous three months and have offloaded domestic shares worth Rs 1,48,149 crore. FIIs sold domestic equities worth Rs 78,027 crore in January and followed it up with selling worth Rs 34,574 crore in February and Rs 3,973 crore in March. On Friday, FIIs sold shares worth Rs 2,519.03 crore while the domestic institutional investors (DIIs) were net buyers at Rs 3,759.27. The FIIs were sellers seven times on a monthly basis in the financial year that ended on March 31, 2025. The highest exodus of flows happened in October and January when the FIIs sold shares worth Rs 94,017 crore and Rs 78,027 crore, respectively. Commenting on the day's action, VK Vijayakumar, Chief Investment Strategist at Geojit Investments said that the turbulence in global ...

[hfe_template id='11223'] [ad_1] Shares of Tata Consultancy Services (TCS) on Friday dropped 1% to Rs 3,212.10 on the BSE after the IT major reported a weaker-than-expected Q4 performance. Consolidated net profit for Q4FY25 declined 1.7% year-on-year to Rs 12,224 crore, falling short of the analysts’ estimate of Rs 12,650 crore. In the year-ago quarter, the net profit was Rs 12,434 crore. Revenue from operations rose 5.3% YoY to Rs 64,479 crore, also missing the ET NOW poll estimate of Rs 64,856 crore. Should you buy, sell, or hold TCS' stock? Here's what analysts say: Centrum Centrum upgraded TCS to ‘Buy’ with a revised target price of Rs 4,211 (down from Rs 4,589), valuing the stock at 25x FY27E EPS. While it flagged muted near-term demand due to macro and geopolitical uncertainties and slower client decision-making, it pointed to strong GenAI deal momentum as a key positive. Centrum sees margin tailwinds from better utilisation, pyramid optimisation, automatio...